Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

investor.lilly.com

Eli Lilly and Company News Releases

Get the latest updates from Eli Lilly and Company News Releases directly as they happen.

Follow now 257 followers

Latest posts

Last updated about 10 hours ago

Lilly's Kisunla (donanemab-azbt) showed growing benefit over three years in early symptomatic Alzheimer's disease

about 10 hours ago

Findings from the TRAILBLAZER-ALZ 2 long-term extension study highlight Kisunla continued to...

Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

5 days ago

INDIANAPOLIS , July 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE...

Lilly confirms date and conference call for second-quarter 2025 financial results announcement

6 days ago

INDIANAPOLIS , July 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE...

Lilly and Verve announce expiration of Verve tender offer

6 days ago

INDIANAPOLIS , July 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE...

FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease

21 days ago

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the...

FDA approves updated label for Lilly’s Amyvid (florbetapir F 18 injection) to support diagnosis of Alzheimer’s disease in patients

about 1 month ago

INDIANAPOLIS, JUNE 25, 2025 – Eli Lilly and Company (NYSE: LLY) announced...

Lilly declares third-quarter 2025 dividend

about 1 month ago

INDIANAPOLIS , June 23, 2025 /PRNewswire/ -- The board of directors of...

Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

about 1 month ago

Verve's leading programs aim to deliver lifelong cardiovascular risk reduction with a...